Juliet Fink

Juliet Fink

Auto-generated profile, based on publicly available information

Juliet Fink

Emory University School of Medicine, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Cell Reports
Verified
Journal Article
Open access
JPJoo-Young Park
Joo-Young Park
DDDevon T. DiPalma
Devon T. DiPalma
JKJuntae Kwon
Juntae Kwon
JFJuliet Fink
Juliet Fink
JPJung-Hyun Park
Jung-Hyun Park
Zbtb16 encodes the zinc-finger protein PLZF, which is often used as a lineage marker for innate-like T cells and is specifically required for the generation of invariant natural killer T (iNKT) cells in the thymus. Here, we report that not only PLZF expression itself but also the relative abundance of PLZF proteins plays critical roles in iNKT cell development. Utilizing a Zbtb16 hypomorphic allele, PLZFGFPCre, which produces PLZF proteins at only half of the level of the wild-type allele, we show that decreased PLZF expression results in a significant decrease in iNKT cell numbers, which is further associated with profound alterations in iNKT lineage choices and subset composition. These results document that there is a quantitative aspect of PLZF expression in iNKT cells, demonstrating that the availability of PLZF protein is a critical factor for both effective iNKT cell generation and subset differentiation.

1 January 2019 in Immune Network
Verified
Journal Article
Open access
PDF file
JPJoo-Young Park
Joo-Young Park
JKJuntae Kwon
Juntae Kwon
EKEmily Y. Kim
Emily Y. Kim
JFJuliet Fink
Juliet Fink
HKHye Kyung Kim
Hye Kyung Kim
JPJung-Hyun Park
Jung-Hyun Park
Park JY, et al. Immune Netw. 2019 Feb;19(2):e14. https://doi.org/10.4110/in.2019.19.e14

18 July 2023 in Foot & Ankle Orthopaedics
Verified
Journal Article
Open access
MCMyra Chao
Myra Chao
WMWesley J. Manz
Wesley J. Manz
JFJuliet Fink
Juliet Fink
MCMichelle M. Coleman
Michelle M. Coleman
RKRishin J. Kadakia
Rishin J. Kadakia
JBJason T. Bariteau
Jason T. Bariteau
Background: The rising prevalence of obesity among American adults has disproportionately affected Black adults and women. Furthermore, body mass index (BMI) has historically been used as a relative contraindication to many total joint arthroplasty (TJA) procedures, including total ankle arthroplasty. The purpose of this study was to investigate potential disparities in patient eligibility for total ankle arthroplasty based on race, ethnicity, sex, and age by applying commonly used BMI cutoffs to the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. Methods: Patients in the ACS-NSQIP database who underwent TAA from 2011 to 2020 were retrospectively reviewed in a cross-sectional analysis. BMI cutoffs of <50, <45, <40, and <35 were then applied. The eligibility rate for TAA was examined for each BMI cutoff, and findings were stratified by race, ethnicity, sex, and age. Independent t tests, chi-squared tests, and Fisher exact tests were performed to compare differences at an α = 0.05. Results: A total of 1215 of 1865 TAA patients (65.1%) were included after applying the exclusion criteria. Black patients had disproportionately lower rates of eligibility at the most stringent BMI cutoff of <35 ( P = .004). Hispanic patients had generally lower rates of eligibility across all BMI cutoffs. In contrast, Asian American and Pacific Islander patients had higher rates of eligibility at the BMI cutoffs of <35 ( P = .033) and <40 ( P = .039), and White non-Hispanic patients had higher rates of eligibility across all BMI cutoffs. Females had lower eligibility rates across all BMI cutoffs. Ineligible patients were also younger compared to eligible patients across all BMI cutoffs. Conclusion: Stringent BMI cutoffs may disproportionately disqualify Black, female, and younger patients from receiving total ankle arthroplasty. Level of Evidence: Level III, retrospective cross-sectional study.

21 July 2023 in Geriatric Orthopaedic Surgery & Rehabilitation
Verified
Journal Article
Open access
WMWesley Manz
Wesley Manz
JNJoseph Novack
Joseph Novack
JFJuliet Fink
Juliet Fink
JJJoseph Jacobson
Joseph Jacobson
JBJason Bariteau
Jason Bariteau
Chronic, non-traumatic pathologies of the foot and ankle can be mobility-limiting for patients of all ages. The objective of this study was to compare postoperative changes in LifeSpace Mobility Assessment (LSA) scores of adult and elderly patients following elective foot and ankle surgery. A prospective study of 184 patients undergoing elective ankle, hindfoot, and midfoot procedures conducted by one surgeon between 2015 and 2019 was undertaken. Patient-reported LSA scores were collected at preoperative, 6-month, and 12-month follow-up. Patient data was compared using an independent sample t-test for continuous, normally distributed data and a chi-squared or Fischer’s exact test for categorical data. Alpha and beta were .05 and .8. Patients were divided based on age. 140 patients were observed in the younger (<65) group, 44 patients were observed in the elderly (≥65) group. The average LSA score of elderly patients at the preoperative visit was 58.3 (SD 38.0) vs 79.3 (SD 38.8) in the younger cohort (P = .041). Both patient cohorts saw decreased mobility at 3-month postoperative visits but surpassed preoperative mobility scores by 6 months and 1 year postop. No difference in average mobility score was observed between young (85.6, SD 36.1) and elderly (90.1, SD 34.3) cohorts at 1-year follow up. Given the increased rates of perioperative comorbidities and the heightened risks of intraoperative complications, physicians may be more inclined to manage elderly patients with longer periods of conservative treatment for similar pathologies. However, these results imply that elderly patients experience similar improvements after surgery to younger cohorts and should not be excluded from surgical consideration. Our results, in tandem with literature showing the deleterious effects of decreased mobility in the elderly, suggest that the discussion to pursue or hold surgical correction of chronic foot and ankle disease in patients over age 65 must consider the mobility benefits of surgery.

1 January 2023 in Foot & Ankle Orthopaedics
Verified
Journal Article
Open access
WMWesley J. Manz
Wesley J. Manz
JFJuliet Fink
Juliet Fink
JNJoseph Novack
Joseph Novack
JJJoseph Jacobson
Joseph Jacobson
JBJason T. Bariteau
Jason T. Bariteau
Background: Limited literature examines the relationship between surgical outcomes in chronic foot and ankle conditions and concurrent psychiatric care. The present study aimed to investigate patient-reported and surgical outcomes of patients treated for a psychiatric disorder undergoing first metatarsophalangeal (MTP) fusion for hallux rigidus. We hypothesized that patients on psychotropic medications would have greater subjective pain preoperatively and less improvement in physical and mental functionality postoperatively when compared with nonmedicated patients. Methods: A single-center, retrospective review of prospectively collected data was conducted on 92 patients undergoing first MTP fusion with a preoperative diagnosis of hallux rigidus from 2015 to 2019. At their preoperative, 6-month postoperative, and 1-year postoperative visits, patients were administered visual analog pain scale (VAS) and 36-Item Short Form Health Survey (SF-36) functionality surveys. Patients were subsequently identified by chronic use of psychotropic medication preoperatively and grouped for analysis (MED, n = 42; NO MED, n = 50). Results: Postoperative mean VAS pain scores were lower for all studied patients at 6 months (VAS = 1.6 ± 2.3) and 1 year postoperatively (VAS = 1.1± 1.8) relative to the preoperative visit (VAS = 4.7 ± 2.8) ( P ≤ .0001 and P ≤ .0001, respectively). No differences in mean VAS pain scores nor SF-36 physical component summary scores were detected at preoperative, 6-month, or 1-year visits between NO MED and MED groups. Mean SF-36 mental component summary scores for those in the MED group were lower at preoperative (NO MED = 83.8, MED = 71.8, P = .006) and 6-month postoperative (NO MED = 86.1, MED = 72.7, P = .037) visits than those in the NO MED group, a trend not observed at the 1-year postoperative mark (NO MED = 84.1, MED = 76.8, P = .228). There were no observed differences in operative time ( P = .219), tourniquet time ( P = .359), nor time to full weightbearing ( P = .512) between MED and NO MED groups. Additionally, no differences in postoperative complication rates were observed between groups. Conclusion: In patients treated with psychotropically active medications with hallux rigidus, MTP Fusion appears to be a reasonable treatment choice with similar outcomes for patients requiring psychotropically active medications to the outcomes of those patients not requiring psychotropically active medications. Level of Evidence: Level III, retrospective comparative study.

1 October 2023 in Foot & Ankle Orthopaedics
Verified
Journal Article
Open access
MCMyra Chao
Myra Chao
WMWesley Manz
Wesley Manz
JNJoseph Novack
Joseph Novack
JFJuliet Fink
Juliet Fink
RKRishin J. Kadakia
Rishin J. Kadakia
JBJason T. Bariteau
Jason T. Bariteau
Category: Ankle; Other Introduction/Purpose: The rising prevalence of obesity may drastically affect arthroplasty eligibility as Body Mass Index (BMI) remains a commonly used screening criterion. As obesity disproportionately affects Black adults and women, using such a criterion without scientific merit may lead to inequitable access to care. Particularly in total ankle arthroplasty – where weight has been previously attributed to aseptic implant failure – close examination of screening criteria is imperative. The purpose of this study was to evaluate for disparities in patient eligibility for total ankle arthroplasty (TAA) based on race, ethnicity, gender, and age by applying commonly used BMI cutoffs to the American College of Surgeons National Surgical Quality Improvement Program (ACS- NSQIP) database. Methods: Patients in the ACS-NSQIP database who underwent TAA from 2011- 2020 were retrospectively reviewed. BMI cutoffs of < 35, < 40, < 45, and < 50 were applied to the cohort to model the rate of surgical eligibility for TAA. Patients were deemed eligible for surgery if their BMI was less than each modeled BMI cutoff and ineligible if their BMI was equal to or greater than the cutoff. The relative eligibility rate, which was defined as the rate of eligibility minus the rate of ineligibility, was examined for each BMI cutoff. The cohorts were then stratified by race, ethnicity, gender, and age. Independent T-tests, Chi-squared tests, and Fisher’s exact tests were performed to compare differences at an α = 0.05. Results: 65.1% of all TAA patients were included after applying the exclusion criteria. Black patients had disproportionately lower rates of eligibility at the most stringent BMI cutoff of < 35kg/m² (p=0.004). Hispanic patients had generally lower rates of eligibility across all BMI cutoffs. In contrast, Asian American and Pacific Islander patients had higher rates of eligibility at the BMI cutoffs of < 35kg/m² (p=0.033) and < 40kg/m² (p=0.039), and White non-Hispanic patients had higher rates of eligibility across all BMI cutoffs. Females had lower eligibility rates across all BMI cutoffs. Ineligible patients were also younger compared to eligible patients across all BMI cutoffs. Conclusion: Stringent BMI cutoffs may disproportionately disqualify Black, female, and younger patients from receiving total ankle arthroplasty. The data suggests that current eligibility criteria may exacerbate disparity in access to TAA for historically vulnerable populations. While eligibility criteria exist to protect patients from interventions that put them at unacceptable risk, these criteria are not uniformly distributed across populations. Given these data and the rising obesity epidemic, additional highly powered studies are needed to determine the safety of TAA in patients with BMI 35-40 to ensure at-risk populations are not disproportionately excluded from mobility-improving surgery.